One sure-fire prediction for 2021 is that Covid-19 will be the biggest health story of the year.
What is worryingly far from clear is how much closer we will be to ending the pandemic a year from now.
But as vaccines start to come on line, the signs are that the answer will lie in decisions made not by scientists or politicians, but each one of us.
Here we look at what the year ahead could hold for us.
An epidemic of errors
Last December, when doctors in Wuhan, central China, first reported cases of a mysterious respiratory illness caused a new virus, the official response was denial – followed by reprimands for spreading false rumours.
Beyond China, the outbreak initially sparked little concern. Inoculated through years of reports of viruses flaring up and fading away again, Covid-19 was put into the same box as Sars, Mers and swine-flu: nasty pieces of work if you get them - which you almost certainly won’t.
Of all the insights about Covid-19 gleaned in 2020, the most critical has been that this virus metes out severe punishment to the complacent and careless
That complacency vanished last January, as outbreaks emerged around the world and China put 60 million of its citizens under lockdown.
But as governments turned to the global research community for answers, complacency mutated into the belief that by “following the science” the virus would quickly be brought under control. As they put their countries under lockdown politicians – notably British Prime Minister Boris Johnson – talked of turning the tide against the virus within a few months.
But of all the insights about Covid-19 gleaned in 2020, the most critical has been that this virus metes out severe punishment to the complacent and careless.
This is what lies behind the stark reality that 2021 will begin with a pandemic that has already claimed over 1.7 million lives – and is still accelerating. How next year ends will depend on how well we avoid the complacency and carelessness of the past 12 months.
The need for speed
The emergence of a new, apparently far more infectious, variant of the original Covid-19 virus provides the first test of whether lessons have been learned. One of the most disastrous blunders was made in the very early days of the pandemic: a failure to recognise the need for speed.
Epidemics spread with exponential speed, with case-numbers increasing not like 1, 2, 3, 4 etc, but as 1, 2, 4, 8 – or even faster. Scientists capture this rate of spread by estimating how long it takes for the case numbers to double. Getting this figure wrong by even a few days leads can lead to disastrous delays in tackling the virus.
This does more than just give the virus more time to infect people, however. The mathematics of exponential growth shows the impact of the delay is permanently locked into the statistics. Experts have estimated that by getting the doubling time wrong by just two days, the resulting delay in the UK lockdown in March led to tens of thousands of unnecessary deaths.
Ever since, the UK government’s scientific advisors have been desperate to avoid making the same mistake. As soon as data on the spread of the new form of the Covid-19 virus became available, they began lobbying Mr Johnson to impose strict controls on most of South-East England over Christmas, regardless of the political or economic cost.
Testing times
While the swift reaction of the UK and other countries to the new variant is encouraging, the form of the response is less so. Within days of declaring the Covid-19 pandemic, the WHO said the key to extinguishing the virus was to "test, test, test".
Implementing that simple mantra remains anything but simple, however. Many countries still lack sufficient testing kits, even in the final days of 2020. But even when they are available, a trickier problem has emerged: how to interpret the outcome.
Experts stressed that all the tests have false-negative and false-positive rates – that is, a probability of wrongly giving the all-clear to those carrying the virus, or vice versa.
The so-called gold standard PCR test is regarded as having the lowest error rate, but it is expensive and slow. This led to greater use of faster, cheaper but less reliable tests.
One way to cut the risk of mis-diagnosis is to restrict testing to people who already have symptoms consistent with Covid-19: a persistence cough, fever and loss of a sense of smell – as these alone are quite strong evidence of infection.
But many people carrying the virus do not have symptoms. Understandable concern about identifying these “asymptomatic” carriers led some countries to use the fast, cheap tests across the board. Even now, the impact of this on the reliability of key data about the prevalence of the virus remains unclear.
The issue of testing flared again with the emergence of the new, more infectious form of Covid-19 virus. Some governments want to test for it using the "gold standard" PCR test. Yet this too is now under suspicion, its high sensitivity raising the risk of giving positive results with people who have long since recovered from Covid-19 and no longer pose a threat.
Many experts have stressed that the way forward lies in frequent testing plus effective contact tracing. The ability of governments to set up and maintain such testing systems will play a key role in their success against the virus over the coming year.
Lockdowns: too high a price to pay?
In the absence of wonder-cure or vaccines, lockdowns were the obvious – if drastic - first line of defence against Covid-19. And in some countries, notably China and South Korea, they appear to have worked.
Yet many other countries have found that lockdowns can prove worse than useless. While case numbers plunged once imposed, the end of lockdowns led to second waves with death rates dwarfing those of the initial outbreaks.
Scientists are already warning of impending third waves of infection. The surges reflect another vicious aspect of the pandemic: how it forces governments to make invidious choices.
Even before the second waves emerged researchers cautioned that the rapid decline in cases following lockdowns could sucker governments into lifting them too early as concern switches to saving the economy. The still-rampant virus then comes roaring back as it regains access to new victims.
Trapped between the rock of Covid-19 and the hard place of economic collapse, governments have tried avoiding nationwide lockdowns with strategies such as regional “tiers” with varying levels of restrictions. But their complexity, varying socio-demographic impact and variable success will likely see them eclipsed by the Great White Hope for defeating the virus: vaccines.
Here come the vaccines
Around the world, thousands of scientists have dropped long-standing projects to join huge research programmes to fight the virus. It quickly emerged that even such basic issues as how respiratory viruses are spread and the effectiveness of masks had never been properly studied. Bitter disputes broke out between experts wielding small, badly-executed and misinterpreted studies.
While simple but potentially valuable measures such as antiseptic gargling were dismissed out of hand, huge sums were spent investigating "cutting-edge" therapies which then failed to live up to their billing.
The WHO Solidarity trial, involving Covid-19 patients in 30 countries, found that none of the sophisticated anti-viral drugs tried against the virus had any clear impact. Ironically, the only drug found to bring major benefit is dexamethasone, an old, cheap drug for calming the immune system.
While headlines trumpet the 90-plus per cent "effectiveness" of some vaccines, how effective they are in stopping vaccinated people acting as carriers remains unknown
Fortunately for the scientific community, these embarrassments have been eclipsed by their triumph in developing a whole suite of vaccines that have proved effective in clinical trials against Covid-19.
The first few – including two based on entirely novel ideas – have already been approved, and are now being rolled out. Unlike the restricted access offered by most countries, the UAE is making proven vaccines from Sinopharm and Pfizer-BioNTech available to most adults in the Emirates, free of charge.
But there are concerns that vaccination cannot live up to the hopes pinned on it. While headlines trumpet the 90-plus per cent “effectiveness” of some vaccines in preventing Covid-19, how effective they are in stopping vaccinated people acting as inadvertent carriers remains unknown.
And even the perfect vaccine won’t stop the pandemic unless enough people are vaccinated fast enough.
Over the coming months, billions of doses will have to be made and shipped around the world. But the biggest challenge may be overcoming the reluctance of people to be vaccinated. Surveys suggest that in some countries barely 50 per cent of people may accept vaccination – far too low to halt the pandemic.
We enter the new year with many critical questions still unanswered. But it is clear that 2021 will be the year when responsibility for ending the pandemic shifts decisively into the hands of each one of us.
Robert Matthews is visiting professor of science at Aston University, Birmingham, UK
Mercer, the investment consulting arm of US services company Marsh & McLennan, expects its wealth division to at least double its assets under management (AUM) in the Middle East as wealth in the region continues to grow despite economic headwinds, a company official said.
Mercer Wealth, which globally has $160 billion in AUM, plans to boost its AUM in the region to $2-$3bn in the next 2-3 years from the present $1bn, said Yasir AbuShaban, a Dubai-based principal with Mercer Wealth.
“Within the next two to three years, we are looking at reaching $2 to $3 billion as a conservative estimate and we do see an opportunity to do so,” said Mr AbuShaban.
Mercer does not directly make investments, but allocates clients’ money they have discretion to, to professional asset managers. They also provide advice to clients.
“We have buying power. We can negotiate on their (client’s) behalf with asset managers to provide them lower fees than they otherwise would have to get on their own,” he added.
Mercer Wealth’s clients include sovereign wealth funds, family offices, and insurance companies among others.
From its office in Dubai, Mercer also looks after Africa, India and Turkey, where they also see opportunity for growth.
Wealth creation in Middle East and Africa (MEA) grew 8.5 per cent to $8.1 trillion last year from $7.5tn in 2015, higher than last year’s global average of 6 per cent and the second-highest growth in a region after Asia-Pacific which grew 9.9 per cent, according to consultancy Boston Consulting Group (BCG). In the region, where wealth grew just 1.9 per cent in 2015 compared with 2014, a pickup in oil prices has helped in wealth generation.
BCG is forecasting MEA wealth will rise to $12tn by 2021, growing at an annual average of 8 per cent.
Drivers of wealth generation in the region will be split evenly between new wealth creation and growth of performance of existing assets, according to BCG.
Another general trend in the region is clients’ looking for a comprehensive approach to investing, according to Mr AbuShaban.
“Institutional investors or some of the families are seeing a slowdown in the available capital they have to invest and in that sense they are looking at optimizing the way they manage their portfolios and making sure they are not investing haphazardly and different parts of their investment are working together,” said Mr AbuShaban.
Some clients also have a higher appetite for risk, given the low interest-rate environment that does not provide enough yield for some institutional investors. These clients are keen to invest in illiquid assets, such as private equity and infrastructure.
“What we have seen is a desire for higher returns in what has been a low-return environment specifically in various fixed income or bonds,” he said.
“In this environment, we have seen a de facto increase in the risk that clients are taking in things like illiquid investments, private equity investments, infrastructure and private debt, those kind of investments were higher illiquidity results in incrementally higher returns.”
The Abu Dhabi Investment Authority, one of the largest sovereign wealth funds, said in its 2016 report that has gradually increased its exposure in direct private equity and private credit transactions, mainly in Asian markets and especially in China and India. The authority’s private equity department focused on structured equities owing to “their defensive characteristics.”
Results
4.30pm Jebel Jais – Maiden (PA) Dh60,000 (Turf) 1,000m; Winner: MM Al Balqaa, Bernardo Pinheiro (jockey), Qaiss Aboud (trainer)
5pm: Jabel Faya – Maiden (PA) Dh60,000 (T) 1,000m; Winner: AF Rasam, Tadhg O’Shea, Ernst Oertel
5.30pm: Al Wathba Stallions Cup – Handicap (PA) Dh70,000 (T) 2,200m; Winner: AF Mukhrej, Tadhg O’Shea, Ernst Oertel
6pm: The President’s Cup Prep – Conditions (PA) Dh100,000 (T) 2,200m; Winner: Mujeeb, Richard Mullen, Salem Al Ketbi
6.30pm: Abu Dhabi Equestrian Club – Prestige (PA) Dh125,000 (T) 1,600m; Winner: Jawal Al Reef, Antonio Fresu, Abubakar Daud
7pm: Al Ruwais – Group 3 (PA) Dh300,000 (T) 1,200m; Winner: Ashton Tourettes, Pat Dobbs, Ibrahim Aseel
7.30pm: Jebel Hafeet – Maiden (TB) Dh80,000 (T) 1,400m; Winner: Nibraas, Richard Mullen, Nicholas Bachalard
SPECS
%3Cp%3E%3Cstrong%3EEngine%3A%3C%2Fstrong%3E%201.5-litre%204-cylinder%3Cbr%3E%3Cstrong%3EPower%3A%3C%2Fstrong%3E%20101hp%3Cbr%3E%3Cstrong%3ETorque%3A%3C%2Fstrong%3E%20135Nm%3Cbr%3E%3Cstrong%3ETransmission%3C%2Fstrong%3E%3A%20Six-speed%20auto%3Cbr%3E%3Cstrong%3EPrice%3A%3C%2Fstrong%3E%20From%20Dh79%2C900%3Cbr%3E%3Cstrong%3EOn%20sale%3A%3C%2Fstrong%3E%20Now%3C%2Fp%3E%0A
The White Lotus: Season three
Creator: Mike White
Starring: Walton Goggins, Jason Isaacs, Natasha Rothwell
Rating: 4.5/5
Awar Qalb
Director: Jamal Salem
Starring: Abdulla Zaid, Joma Ali, Neven Madi and Khadija Sleiman
Two stars
Best Foreign Language Film nominees
Capernaum (Lebanon)
Cold War (Poland)
Never Look Away (Germany)
Roma (Mexico)
Shoplifters (Japan)
Mohammed bin Zayed Majlis
The biog
Mission to Seafarers is one of the largest port-based welfare operators in the world.
It provided services to around 200 ports across 50 countries.
They also provide port chaplains to help them deliver professional welfare services.
ILT20%20UAE%20stars
%3Cp%3E%3Cstrong%3ELEADING%20RUN%20SCORERS%3C%2Fstrong%3E%3Cbr%3E1%20Nicholas%20Pooran%2C%20261%3Cbr%3E%3Cstrong%3E2%20Muhammad%20Waseem%20(UAE)%2C%20248%3C%2Fstrong%3E%3Cbr%3E3%20Chris%20Lynn%2C%20244%3Cbr%3E4%20Johnson%20Charles%2C%20232%3Cbr%3E5%20Kusal%20Perera%2C%20230%3Cbr%3E%3Cbr%3E%3Cstrong%3EBEST%20BOWLING%20AVERAGE%3C%2Fstrong%3E%3Cbr%3E(minimum%2010%20overs%20bowled)%3Cbr%3E%3Cstrong%3E1%20Zuhaib%20Zubair%20(UAE)%2C%209%20wickets%20at%2012.44%3Cbr%3E2%20Mohammed%20Rohid%20(UAE)%2C%207%20at%2013.00%3C%2Fstrong%3E%3Cbr%3E3%20Fazalhaq%20Farooqi%2C%2017%20at%2013.05%3Cbr%3E4%20Waqar%20Salamkheil%2C%2010%20at%2014.08%3Cbr%3E%3Cstrong%3E5%20Aayan%20Khan%20(UAE)%2C%204%20at%2015.50%3C%2Fstrong%3E%3Cbr%3E6%20Wanindu%20Hasaranga%2C%2012%20at%2016.25%3Cbr%3E%3Cstrong%3E7%20Mohammed%20Jawadullah%20(UAE)%2C%2010%20at%2017.00%3C%2Fstrong%3E%3C%2Fp%3E%0A
Ten tax points to be aware of in 2026
1. Domestic VAT refund amendments: request your refund within five years
If a business does not apply for the refund on time, they lose their credit.
2. E-invoicing in the UAE
Businesses should continue preparing for the implementation of e-invoicing in the UAE, with 2026 a preparation and transition period ahead of phased mandatory adoption.
3. More tax audits
Tax authorities are increasingly using data already available across multiple filings to identify audit risks.
4. More beneficial VAT and excise tax penalty regime
Tax disputes are expected to become more frequent and more structured, with clearer administrative objection and appeal processes. The UAE has adopted a new penalty regime for VAT and excise disputes, which now mirrors the penalty regime for corporate tax.
5. Greater emphasis on statutory audit
There is a greater need for the accuracy of financial statements. The International Financial Reporting Standards standards need to be strictly adhered to and, as a result, the quality of the audits will need to increase.
6. Further transfer pricing enforcement
Transfer pricing enforcement, which refers to the practice of establishing prices for internal transactions between related entities, is expected to broaden in scope. The UAE will shortly open the possibility to negotiate advance pricing agreements, or essentially rulings for transfer pricing purposes.
7. Limited time periods for audits
Recent amendments also introduce a default five-year limitation period for tax audits and assessments, subject to specific statutory exceptions. While the standard audit and assessment period is five years, this may be extended to up to 15 years in cases involving fraud or tax evasion.
8. Pillar 2 implementation
Many multinational groups will begin to feel the practical effect of the Domestic Minimum Top-Up Tax (DMTT), the UAE's implementation of the OECD’s global minimum tax under Pillar 2. While the rules apply for financial years starting on or after January 1, 2025, it is 2026 that marks the transition to an operational phase.
9. Reduced compliance obligations for imported goods and services
Businesses that apply the reverse-charge mechanism for VAT purposes in the UAE may benefit from reduced compliance obligations.
10. Substance and CbC reporting focus
Tax authorities are expected to continue strengthening the enforcement of economic substance and Country-by-Country (CbC) reporting frameworks. In the UAE, these regimes are increasingly being used as risk-assessment tools, providing tax authorities with a comprehensive view of multinational groups’ global footprints and enabling them to assess whether profits are aligned with real economic activity.
Contributed by Thomas Vanhee and Hend Rashwan, Aurifer
The specs
Engine: 6.2-litre V8
Power: 502hp at 7,600rpm
Torque: 637Nm at 5,150rpm
Transmission: 8-speed dual-clutch auto
Price: from Dh317,671
On sale: now
Our family matters legal consultant
Name: Hassan Mohsen Elhais
Position: legal consultant with Al Rowaad Advocates and Legal Consultants.
PAKISTAN SQUAD
Pakistan - Sarfraz Ahmed (captain), Azhar Ali, Fakhar Zaman, Imam-ul-Haq, Babar Azam, Shoaib Malik, Mohammad Hafeez, Haris Sohail, Faheem Ashraf, Shadab Khan, Mohammad Nawaz, Mohammad Amir, Hasan Ali, Aamer Yamin, Rumman Raees.
Results
%3Cp%3E%0D%3Cstrong%3EElite%20men%3C%2Fstrong%3E%0D%3Cbr%3E1.%20Amare%20Hailemichael%20Samson%20(ERI)%202%3A07%3A10%0D%3Cbr%3E2.%20Leornard%20Barsoton%20(KEN)%202%3A09%3A37%0D%3Cbr%3E3.%20Ilham%20Ozbilan%20(TUR)%202%3A10%3A16%0D%3Cbr%3E4.%20Gideon%20Chepkonga%20(KEN)%202%3A11%3A17%0D%3Cbr%3E5.%20Isaac%20Timoi%20(KEN)%202%3A11%3A34%0D%3Cbr%3E%3Cstrong%3EElite%20women%3C%2Fstrong%3E%0D%3Cbr%3E1.%20Brigid%20Kosgei%20(KEN)%202%3A19%3A15%0D%3Cbr%3E2.%20Hawi%20Feysa%20Gejia%20(ETH)%202%3A24%3A03%0D%3Cbr%3E3.%20Sintayehu%20Dessi%20(ETH)%202%3A25%3A36%0D%3Cbr%3E4.%20Aurelia%20Kiptui%20(KEN)%202%3A28%3A59%0D%3Cbr%3E5.%20Emily%20Kipchumba%20(KEN)%202%3A29%3A52%3C%2Fp%3E%0A
Breast cancer in men: the facts
1) Breast cancer is men is rare but can develop rapidly. It usually occurs in those over the ages of 60, but can occasionally affect younger men.
2) Symptoms can include a lump, discharge, swollen glands or a rash.
3) People with a history of cancer in the family can be more susceptible.
4) Treatments include surgery and chemotherapy but early diagnosis is the key.
5) Anyone concerned is urged to contact their doctor
How much do leading UAE’s UK curriculum schools charge for Year 6?
- Nord Anglia International School (Dubai) – Dh85,032
- Kings School Al Barsha (Dubai) – Dh71,905
- Brighton College Abu Dhabi - Dh68,560
- Jumeirah English Speaking School (Dubai) – Dh59,728
- Gems Wellington International School – Dubai Branch – Dh58,488
- The British School Al Khubairat (Abu Dhabi) - Dh54,170
- Dubai English Speaking School – Dh51,269
*Annual tuition fees covering the 2024/2025 academic year
In Full Flight: A Story of Africa and Atonement
John Heminway, Knopff
Tuesday's fixtures
Kyrgyzstan v Qatar, 5.45pm
Gully Boy
Director: Zoya Akhtar
Producer: Excel Entertainment & Tiger Baby
Cast: Ranveer Singh, Alia Bhatt, Kalki Koechlin, Siddhant Chaturvedi
Rating: 4/5 stars
Desert Warrior
Starring: Anthony Mackie, Aiysha Hart, Ben Kingsley
Director: Rupert Wyatt
Rating: 3/5